Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Sanna S, Jackson AU, Nagaraja R, et al. "Common variants in the GDF5-UQCC region are associated with variation in human height." Nat Genet. 2008;40(2):198-203.
Santos ABS, Gupta DK, Bello NA, et al. "Prehypertension is Associated With Abnormalities of Cardiac Structure and Function in the Atherosclerosis Risk in Communities Study." Am J Hypertens. 2016;29(5):568-74.
Santos M, Kitzman DW, Matsushita K, Loehr LR, Sueta CA. "Prognostic Importance of Dyspnea for Cardiovascular Outcomes and Mortality in Persons without Prevalent Cardiopulmonary Disease: The Atherosclerosis Risk in Communities Study." PLoS One. 2016;11(10):e0165111.
Sargurupremraj M, Suzuki H, Jian X, et al. "Cerebral small vessel disease genomics and its implications across the lifespan." Nat Commun. 2020;11(1):6285.
Sarnowski C, Leong A, Raffield LM, et al. "Impact of Rare and Common Genetic Variants on Diabetes Diagnosis by Hemoglobin A1c in Multi-Ancestry Cohorts: The Trans-Omics for Precision Medicine Program." Am J Hum Genet. 2019;105(4):706-718.
Sarnowski C, Cousminer DL, Franceschini N, et al. "Large trans-ethnic meta-analysis identifies AKR1C4 as a novel gene associated with age at menarche." Hum Reprod. 2021;36(7):1999-2010.
Sarnowski C, Satizabal CL, DeCarli C, et al. "Whole genome sequence analyses of brain imaging measures in the Framingham Study." Neurology. 2018;90(3):e188-e196.
Sarnowski C, Ghanbari M, Bis JC, et al. "Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total tau levels." Commun Biol. 2022;5(1):336.
Sarnowski C, Chen H, Biggs ML, et al. "Identification of novel and rare variants associated with handgrip strength using whole genome sequence data from the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program." PLoS One. 2021;16(7):e0253611.
Satizabal CL, Adams HHH, Hibar DP, et al. "Genetic architecture of subcortical brain structures in 38,851 individuals." Nat Genet. 2019;51(11):1624-1636.
Saunders JT, Nambi V, de Lemos JA, et al. "Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study." Circulation. 2011;123(13):1367-76.
Savitz ST, Stearns SC, Zhou L, Thudium E, Alburikan KA, Tran R. "A Comparison of Self-reported Medication Adherence to Concordance Between Part D Claims and Medication Possession." Med Care. 2017;55(5):500-505.
Savitz ST, Stearns SC, Groves JS, Kucharska-Newton AMaria, Bengtson LGS. "Mind the Gap: Hospitalizations from Multiple Sources in a Longitudinal Study." Value Health. 2017;20(6):777-784.
Savoca MR, Steffen LM, Bertoni AG. "From Neighborhood to Genome: Three Decades of Nutrition-Related Research from the Atherosclerosis Risk in Communities Study." J Acad Nutr Diet. 2017;117(12):1881-1886.e10.
Schanen JG, Iribarren C, Shahar E, et al. "Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study." Thorax. 2005;60(8):633-8.
Scharpf RB, Mireles L, Yang Q, et al. "Copy number polymorphisms near SLC2A9 are associated with serum uric acid concentrations." BMC Genet. 2014;15:81.
Scheppach JB, Coresh JJ, Wu A, et al. "Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study." Am J Kidney Dis. 2020;76(6):775-783.
Scheppach JB, Wu A, Gottesman RF, et al. "Association of Kidney Function Measures With Signs of Neurodegeneration and Small Vessel Disease on Brain Magnetic Resonance Imaging: The Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2022.
Schick UM, Auer PL, Bis JC, et al. "Association of exome sequences with plasma C-reactive protein levels in >9000 participants." Hum Mol Genet. 2015;24(2):559-71.
Schlosser P, Tin A, Matias-Garcia PR, et al. "Meta-analyses identify DNA methylation associated with kidney function and damage." Nat Commun. 2021;12(1):7174.
Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. "A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study." Diabetes Care. 1996;19(5):414-8.
Schmidt MI, Watson RL, Duncan BB, et al. "Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators." Metabolism. 1996;45(6):699-706.
Schmidt M I, Duncan BB, Bang H, et al. "Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study." Diabetes Care. 2005;28(8):2013-8.
Schmidt MI, Duncan BB, Sharrett AR, et al. "Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study." Lancet. 1999;353(9165):1649-52.
Schmidt MI, Duncan BB, Vigo A, et al. "Leptin and incident type 2 diabetes: risk or protection?" Diabetologia. 2006;49(9):2086-96.
Schmidt M I, Duncan BB, Vigo A, et al. "Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study." Diabetes Care. 2003;26(5):1338-43.
Schmitz KH, Arnett DK, Bank A, et al. "Arterial distensibility and physical activity in the ARIC study." Med Sci Sports Exerc. 2001;33(12):2065-71.
Schneider ALC, Kalyani RR, Golden S, et al. "Diabetes and Prediabetes and Risk of Hospitalization: The Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Care. 2016;39(5):772-9.
Schneider ALC, A Sharrett R, Patel MD, et al. "Education and cognitive change over 15 years: the atherosclerosis risk in communities study." J Am Geriatr Soc. 2012;60(10):1847-53.
Schneider ALC, Sharrett ARichey, Gottesman RF, et al. "Normative data for 8 neuropsychological tests in older blacks and whites from the atherosclerosis risk in communities (ARIC) study." Alzheimer Dis Assoc Disord. 2015;29(1):32-44.
Schneider ALC, Lazo M, Ndumele CE, et al. "Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study." Diabet Med. 2013;30(8):926-33.
Schneider ALC, Selvin E, Sharrett ARichey, et al. "Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)." Diabetes Care. 2017;40(11):1514-1521.
Schneider ALC, Williams EK, Brancati FL, Blecker S, Coresh J, Selvin E. "Diabetes and risk of fracture-related hospitalization: the Atherosclerosis Risk in Communities Study." Diabetes Care. 2013;36(5):1153-8.
Schneider ALC, Wang D, Gottesman RF, Selvin E. "Prevalence of Disability Associated With Head Injury With Loss of Consciousness in Adults in the United States: A Population-Based Study." Neurology. 2021;97(2):e124-e135.
Schneider ALC, Gottesman RF, Krauss GL, et al. "Association of Head Injury With Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Cohort." Neurology. 2022;98(8):e808-e817.
Schneider ALC, Zhao D, Lutsey PL, et al. "Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study." Neuroepidemiology. 2018;51(3-4):131-137.
Schneider ALC, Lutsey PL, Alonso A, et al. "Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study." Eur J Neurol. 2014;21(9):1211-8, e69-70.
Schneider ALC, Selvin E, Liang M, et al. "Association of Head Injury with Brain Amyloid Deposition: The ARIC-PET Study." J Neurotrauma. 2019;36(17):2549-2557.
Schneider ALC, Jonassaint C, Sharrett ARichey, et al. "Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study." J Gerontol A Biol Sci Med Sci. 2016;71(6):772-9.
Schneider ALC, Rawlings AM, Sharrett ARichey, et al. "High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study." Eur Heart J. 2014;35(27):1817-24.
Schneider ALC, Senjem ML, Wu A, et al. "Neural correlates of domain-specific cognitive decline: The ARIC-NCS Study." Neurology. 2019;92(10):e1051-e1063.
Schneider ALC, Selvin E, Latour L, et al. "Head injury and 25-year risk of dementia." Alzheimers Dement. 2021.
Schneider ALC, Gottesman RF, Mosley T, et al. "Cognition and incident dementia hospitalization: results from the atherosclerosis risk in communities study." Neuroepidemiology. 2013;40(2):117-24.
Schneider ALC, Lutsey PL, Selvin E, et al. "Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study." Eur J Neurol. 2015;22(8):1220-7.
Schneider ALC, Pankow JS, Heiss G, Selvin E. "Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2012;176(8):738-43.
Schneider ALC, Gottesman RF, Mosley TH, et al. "Associations of Prior Head Injury With Olfaction in Older Adults: Results From the Atherosclerosis Risk in Communities (ARIC) Study." JAMA Otolaryngol Head Neck Surg. 2022;148(9):840-848.
Schreiner PJ, Wu KK, M Malinow R, et al. "Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study." Ann Epidemiol. 2002;12(4):228-36.
Schreiner PJ. "Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: the Atherosclerosis Risk in Communities (ARIC) Study." Chem Phys Lipids. 1994;67-68:405-10.
Schreiner PJ, Terry JG, Evans GW, Hinson WH, Crouse JR, Heiss G. "Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study." Am J Epidemiol. 1996;144(4):335-45.
Schreiner PJ, Appiah D. "Gamma prime (γ') fibrinogen and carotid intima-media thickness: the Atherosclerosis Risk in Communities study." Blood Coagul Fibrinolysis. 2017;28(8):665-669.
Schreiner PJ, Morrisett JD, Sharrett AR, et al. "Lipoprotein[a] as a risk factor for preclinical atherosclerosis." Arterioscler Thromb. 1993;13(6):826-33.
Schreiner PJ, Heiss G, Tyroler HA, Morrisett JD, Davis CE, Smith R. "Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 1996;16(3):471-8.
Schreiner PJ, Chambless LE, Brown SA, Watson RL, Toole J, Heiss G. "Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities." Ann Epidemiol. 1994;4(5):351-9.
Schroeder EB, Welch V L, Couper D, et al. "Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2003;158(12):1171-81.
Schroeder EB, Welch V L, Evans GW, Heiss G. "Impaired lung function and subclinical atherosclerosis. The ARIC Study." Atherosclerosis. 2005;180(2):367-73.
Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. "Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study." Hypertension. 2003;42(6):1106-11.
Schroeder EB, Chambless LE, Liao D, et al. "Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study." Diabetes Care. 2005;28(3):668-74.
Schroeder EB, Whitsel EA, Evans GW, Prineas RJ, Chambless LE, Heiss G. "Repeatability of heart rate variability measures." J Electrocardiol. 2004;37(3):163-72.
Schultheiss UT, Teumer A, Medici M, et al. "A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations." J Clin Endocrinol Metab. 2015;100(5):E799-807.
Schultheiss UT, Daya N, Grams ME, et al. "Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study." Nephrol Dial Transplant. 2017;32(11):1874-1881.
Schunk SJ, Kleber ME, März W, et al. "Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality." Eur Heart J. 2021;42(18):1742-1756.
Schwartz SW, Carlucci C, Chambless LE, Rosamond WD. "Synergism between smoking and vital exhaustion in the risk of ischemic stroke: evidence from the ARIC study." Ann Epidemiol. 2004;14(6):416-24.
"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe." Eur Heart J. 2021;42(25):2439-2454.
"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions." Eur Heart J. 2021;42(25):2455-2467.
Scott RA, Freitag DF, Li L, et al. "A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease." Sci Transl Med. 2016;8(341):341ra76.
Scott RA, Scott LJ, Mägi R, et al. "An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans." Diabetes. 2017;66(11):2888-2902.
Scott RA, Lagou V, Welch RP, et al. "Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways." Nat Genet. 2012;44(9):991-1005.
Scott RA, Chu AY, Grarup N, et al. "No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels." Diabetes. 2012;61(5):1291-6.
Scutelnic A, Mattle HP, Branca M, et al. "Migraine and atrial fibrillation: a systematic review." Eur J Neurol. 2022;29(3):910-920.
Seaman CD, George KM, Ragni M. "Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities Study." Thromb Res. 2016;144:236-8.
Secora A, G Alexander C, Ballew SH, Coresh JJ. "Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults." Drugs Aging. 2018;35(8):735-750.
Segar MW, Hall JL, Jhund PS, et al. "Machine Learning-Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure." JAMA Cardiol. 2022;7(8):844-854.
Segar MW, Jaeger BC, Patel KV, et al. "Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis." Circulation. 2021;143(24):2370-2383.
Seidelmann SB, Feofanova E, Yu B, et al. "Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk." J Am Coll Cardiol. 2018;72(15):1763-1773.
Seidelmann SB, Claggett B, Cheng S, et al. "Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis." Lancet Public Health. 2018;3(9):e419-e428.
Seidelmann SB, Claggett B, Bravo PE, et al. "Retinal Vessel Calibers in Predicting Long-Term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study." Circulation. 2016;134(18):1328-1338.
Seidelmann SB, Vardeny O, Claggett B, et al. "An Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality." J Am Heart Assoc. 2017;6(4).
Sekula P, Tin A, Schultheiss UT, et al. "Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease." Sci Rep. 2020;10(1):10018.
Selvaraj S, Myhre PL, Vaduganathan M, et al. "Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community." JACC Heart Fail. 2020;8(8):640-653.
Selvaraj S, Claggett B, Johansen MC, et al. "Apolipoprotein E Polymorphism, Cardiac Remodeling, and Heart Failure in the ARIC Study." J Card Fail. 2022;28(7):1128-1136.

Pages